Skip to main content

Table 4 Surgical outcomes

From: Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study

Surgical outcomes

Group 1

(n = 19)

Group 2

(n = 40)

P value

Operation time (min)

324.6 ± 16.6

363.6 ± 11.8

0.064

Blood loss (mL)

150 (100–200)

100 (100–200)

0.310

Harvested lymph nodes, n

23(20–30)

26 (21–32)

0.276

Positive lymph nodes, n

0(0–1)

0(0-1.75)

0.410

Hospital stay (days)

18(16–21)

16.5(13.25–30.50)

0.358